CRISPR is the buzzword of the moment in the drug discovery industry – mainly due to its potential to correct disease-causing mutations. However, those using the technology need to be mindful that it is used responsibly, and possible risks are considered before use. Mark Behlke discusses the potential of CRISPR…
List view / Grid view
Filter the results
Whitepaper: Evaluating the impact of error rate on productivity and cost savings in synthetic DNA fragments
GeneArt High-Q Strings DNA Fragments versus other suppliers’ products.
Application note: Faster and more reliable quantification of oligonucleotide interaction with human serum albumin using MST
Antisense oligonucleotides are an emerging therapeutic option for treating diseases with known genetic origin.
Innovations in synthesis technology and gene synthesis have become a powerful and valuable means of obtaining genetic material.
A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients.
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
The process of Salmonella typhi to damage DNA has been revealed by researchers at the University of Sheffield which could inform treatments.
Researchers have mapped a previously uncharted region of the human genome which could lead to tests for certain conditions in the future.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.